Advanced Filters
noise

Helsinki, Finland Clinical Trials

A listing of Helsinki, Finland clinical trials actively recruiting patients volunteers.

Found 131 clinical trials
T T Jahnukainen, MD

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

The goal of this clinical trial is to learn about the efficacy and safety of imlifidase in highly sensitized paediatric patients, 1-17 years old, with end stage renal disease (ESRD). The main questions it aims to answer are: Does imlifidase treatment result in crossmatch conversion that enables transplantation? How is …

1 - 17 years of age All Phase 2
T Toni Seppala, Prof

Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer

Rectal cancer represents the most complex area of multidisciplinary treatment in bowel surgery. In 2017, there were 1221 new rectal cancers in Finland. The prognosis of colorectal cancer (CRC) patients these days is almost exclusively driven by the occurrence of the metastatic form of the disease. The treatment of rectal …

18 - 100 years of age All Phase N/A
M Meilahti Vaccine Research Center

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

18 - 90 years of age Female Phase 2/3
A Aki Uutela, MD

Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)

Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out …

18 years of age All Phase N/A
P Paula Virtala, PhD

Language Development Deficits and Early Interactive Music Intervention

Investigators compare effects of 6-month music versus circus group interventions on language development in infants and toddlers with or without familial risk for dyslexia (anticipated total N=200). Effects of intervention timing, dyslexia risk and genetics, and social-emotional factors on the intervention outcomes are investigated.

8 - 12 years of age All Phase N/A
P Peeter Karihtala, Prof

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

IMPORTANT study is a multicenter, open-label, prospective, randomized-controlled, non-inferiority trial with a pragmatic approach involving older patients (≥ 70 years old) with advanced hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, not amenable for curative treatment and without prior therapy for advanced disease, who are suitable to …

70 years of age All Phase 3

A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies

This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.

18 years of age All Phase 4
S Samuli Aspinen, M.D., Ph.D.

Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture

Trial purpose is to research the outcome comparing traditional physiotherapy vs telerehabilitation after volar plating of distal radius fracture. Patients with distal radius fracture that meet the operative criteria set by the Finnish Current Care guidelines are randomized (1:1 computer generated sequence with random block size) to two parallel groups …

18 - 65 years of age All Phase N/A

Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome

Carpal tunnel syndrome is a common compression neuropathy of upper extremities. Its usual symptoms are pain, numbness and tingling of fingers, which tend to be worse at night. Splinting the wrist with an external orthosis is usually a first-line treatment provided to most people with mild to moderate disease. The …

18 years of age All Phase N/A
T Terhi Saarikoski, RN

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.

40 years of age All Phase N/A

Simplify language using AI